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Abstract
The present study was undertaken to identify the mechanisms underlying the effect of retinoic acid (RA) on follicle-
stimulating hormone receptor (FSH-R) in rat granulosa cells. Treatment with FSH produced a substantial increase in FSH-R
mRNA level, as was expected, while concurrent treatment with increasing concentrations of RA brought about dose-
dependent decreases in FSH-induced FSH-R mRNA, with a maximal inhibition one-third lower than that induced by FSH
alone. RA, either alone or in combination with FSH, did not affect intracellular cAMP levels, while it inhibited the effect of
8-Br-cAMP on FSH-R mRNA production. These results suggested that RA diminished the action of FSH on FSH-R
expression at sites distal to cAMP generation in the granulosa cells. Whether the effect of RA and FSH on FSH-R mRNA
levels was the result of decreased transcription and/or altered mRNA stability was also investigated. The rate of FSH
receptor mRNA gene transcription, assessed by nuclear run-on transcription assay, was found to decrease by the addition of
RA. On the other hand, the decay curves for the 2.4 kb FSH-R mRNA transcript in primary granulosa cells did not alter the
slope of the FSH-R mRNA decay curve in the presence of RA. Our data suggests for the first time that the effect of RA on
FSH-R expression is possibly mediated by the reduction of the FSH-R mRNA level due to a negative regulation of the FSH-
R gene in the presence of FSH. These findings assist in understanding the molecular mechanism underlying the effect of RA
on reproductive function in rat granulosa cells. ß 2000 Published by Elsevier Science B.V. All rights reserved.
1. Introduction
Follicle-stimulating hormone (FSH) is important
for the early development and maintenance of gran-
ulosa cell function and folliculogenesis in females.
FSH exerts its action through the FSH receptor
(FSH-R), which is a member of the G-protein-
coupled receptor subfamily that also includes the lu-
teinizing hormone/chronic gonadotropin receptor
(LH/hCG-R) and thyroid-stimulating hormone re-
ceptor. The receptors in this subfamily have a large
extracellular domain, a transmembrane region, and
an intracellular domain [1^5].
Data from several laboratories, including our own,
have shown that FSH, a major regulator of FSH
receptor induction, increases FSH receptor mRNA
levels both in vivo and in vitro [6^9]. Many of the
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e¡ects of FSH on granulosa cells are mediated by the
cyclic AMP (cAMP) second messenger system [10]. A
model system that has been widely used to study this
phenomenon consists of primary cultures of rat gran-
ulosa cells obtained from immature female rats pre-
treated with estradiol. The use of this de¢ned system
has shown that the ability of FSH to stimulate the
induction of FSH receptors is mediated, at least in
part, by cAMP, since exogenous cAMP or other
agents that increase intracellular levels of cAMP
mimic the actions of FSH [9].
The promoters for this FSH-R gene in the rat,
mouse, and human are members of a class of pro-
moters that lack a conventional TATA and CCAT
box and have multiple transcriptional start sites [11^
13]. Several DNA elements have been identi¢ed in
the 3P proximal region of the promoter for the
FSH-R in rats, humans, and mice. For example, in
a paper by Goetz et al. [14], an E box is required for
full promoters of the rat, human, sheep, and mouse
FSH-R genes which all contain an E box consensus
sequence known to bind members of the basic helix-
loop-helix (bHLH) family of proteins.
Early studies showed the presence of vitamin A in
the ovary and its £uctuation in serum during the
menstrual cycle, indicating that vitamin A may play
a role in ovarian function [15,16]. It is known that
retinoic acid, the primary active metabolite of vita-
min A, mediates biological e¡ects on target cells
through nuclear receptors (retinoic acid receptors
and retinoid-X receptors (RARs/RXRs)) that are
members of steroid/thyroid hormone nuclear recep-
tor superfamily. These receptors interact with retino-
ic acid response elements in the promoter region of
various target genes [17]. The ovary has been shown
to express RARs, consistent with its being a target
for retinoic acid action [18]. Retinoic acid (RA) and
other vitamin A derivatives are known to have di¡er-
ent important roles in cellular di¡erentiation, prolif-
eration, and homeostasis [19^23]. The heterogeneity
of these responses suggests the existence of complex
signaling pathways to account for the diverse e¡ects
of retinoids, but the molecular events involved in
retinoid-mediated regulation of gene expression are
not yet fully characterized [24^29]. The present study
was undertaken to elucidate the molecular mecha-
nisms underlying the inhibition of FSH mRNA by
RA in the presence of FSH.
2. Materials and methods
2.1. Hormones and reagents
Rat FSH (I-8) was obtained from the National
Hormone and Pituitary Distribution Program (Be-
thesda, MD). Diethylstilbestrol (DES), gentamicin
sulfate, 8-brom-adenosine 3,5-cyclic monophosphate
(8-Br-cAMP) Retinoic acid (RA) were purchased
from Sigma (St. Louis, MO). Dulbecco’s modi¢ed
Eagle’s (DEM) medium, Ham’s F-12 medium, and
fungizone were purchased from Gibco (Grand Is-
land, NY). The RNA labeling kit and nucleic acid
detection kit were purchased from Boehringer Mann-
heim (Mannheim, Germany).
2.2. Rat granulosa cell culture
Granulosa cells were obtained from immature fe-
male Wistar rats which received an injection of 2 mg
diethylstilbestrol in 0.1 ml sesame oil once daily for
4 days. The ovaries were then excised, and granulosa
cells were released by puncturing follicles with a
25-gauge needle. At all times, the animals were
treated according to NIH guidelines. Granulosa cells
were washed and collected by brief centrifugation,
and cell viability was determined by Trypan blue
exclusion. The granulosa cells were then cultured in
Ham’s F-12/DME (1:1, v/v) medium supplemented
with 1.1 g/l NaHCO3, 40 mg/l gentamicin sulfate,
1 mg/l fungizone, and 100 mg/l BSA on collagen
coated plates in a humidi¢ed atmosphere containing
5% CO2, 95% air at 37‡C [30].
2.3. Cyclic AMP assays
Granulosa cells (5U105 cells/culture dish) were
washed with warm medium and then preincubated
for 15 min at 37‡C in 0.5 ml medium without serum
in the presence of 0.5 mM 3-isobutyl-1-methylxan-
thine (IBMX) (Sigma, St Louis, MO, USA). Puri¢ed
hormones were added to the dish, and the incubation
was continued for 60 min at 37‡C. After incubation,
the medium was removed and the cells were rinsed
twice with phosphate-bu¡ered saline (PBS) at 4‡C
and lysed with 0.5 ml 95% (v/v) ethanol. Aliquots
of the resulting lysate were centrifuged at 4‡C at
15 000Ug for 15 min. The supernatant was dried
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and resuspended in 0.3 M imidazole bu¡er, pH 6.5.
Intracellular cAMP levels were determined by the
double-antibody radioimmunoassay method [31].
Triplicate plates were analyzed for each data point.
2.4. Preparation of cRNA probes
Rat FSH receptor cDNA was subcloned into the
EcoRI site of the Bluescript KS vector and linear-
ized with HindIII [30]. Digoxigenin-labeled FSH
receptor cRNA probes corresponding to bases
239^2368 were produced by in vitro transcription
with T7 RNA polymerase and an RNA labeling
kit (Boehringer Mannheim). A digoxigenin labeled
GAPDH probe was obtained by the same method.
2.5. RNA isolation and analysis
Granulosa cells were cultured in 60-mm dishes
containing 5U106 viable cells in 5-ml of medium,
and reagents were added to the medium after 24 h
of cell culture. The granulosa cells were further in-
cubated, and the cultures were stopped at the se-
lected time as indicated in the guanidinium acid^
thiocyanate^phenol^chloroform method [32]. The ¢-
nal RNA pellet was dissolved in diethyl pyrocabon-
ate-treated H2O. Total RNA was quanti¢ed by mea-
suring the absorbance of samples at 260 nm. For
Northern blot analysis, 15 Wg total RNA from each
dish was separated by electrophoresis on denaturing
agarose gels and subsequently transferred to a nylon
membrane (Biodyne, ICN, Glen Cove, NY, USA).
In accordance with the standard protocol for the
nucleic acid detection kit (Boehringer Mannheim),
Kodak X-Omat ¢lm (Eastman Kodak, Rochester,
NY) was then exposed to the membranes. Lumines-
cence detection was quanti¢ed with an LKB 2202
UnitroScan Laser Densitometer (LKB, Bromma,
Sweden), normalized against a corresponding relative
amount of GAPDH mRNA in each sample, and ex-
pressed as relative densitometric units [33].
2.6. Isolation of nuclei
Granulosa cells were cultured in 60-mm dishes
containing 5U106 cells in 5 ml serum-free medium.
After the ¢rst 24 h, granulosa cells were further in-
cubated without FSH, with FSH (30 ng/ml) and
combination of FSH (30 ng/ml) plus RA (10 nM)
for a further 24 h, before isolating the nuclei. Cells
were washed three times with ice-cold Dulbecco’s
PBS without calcium and magnesium (PBS3), col-
lected by scraping in PBS3, and then centrifuged
for 5 mm at 1000 rpm at 4‡C. The cell pellet was
resuspended in 500Wl nonidet P-40 lysis bu¡er
(10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM
MgCl2, 0.5% nonidet P-40). Lysed cells were incu-
bated on ice for 10 min and centrifuged for 5 min
at 3000 rpm. The nuclear pellet was then resus-
pended in 500 Wl nonidet P-40 lysis bu¡er and cen-
trifuged for 5 min. The ¢nal nuclear pellet was gently
resuspended in 100 Wl glycerol storage bu¡er (50 mM
Tris-HCl, pH 8.3, 40% glycerol, 5 mM MgCl2,
0.1 mM EDTA, pH 8.0), frozen in liquid nitrogen
and stored at 380‡C.
2.7. Run-on transcription assay
The nuclear run-on transcription assay was per-
formed according to a previously described protocol
[32]. The relative amount of incorporation of
label into speci¢c RNAs was determined by DNA
excess ¢lter hybridization, using cDNAs for rat
FSH-R, as described previously [34]. Five micro-
grams each of FSH-R, Bluescript, and actin cDNAs
were included on the DNA ¢lter during hybridiza-
tion in order to correct for background and to serve
as internal controls. Autoradiographic bands were
quanti¢ed by a £uoro-image analyzer (BAS 2000,
Fuji, Japan).
2.8. Transcription stability analysis
Cells were preincubated with FSH alone or FSH
and RA for 24 h before the addition of 5 M actino-
mycin-D to arrest new RNA synthesis. Cells were
harvested at 0, 3, 6 and 9 h after the addition of
the inhibitor, for RNA extraction and Northern
blot analysis.
2.9. Data analysis
The relative abundance of a 2.4-kb signal for rat
FSH-R mRNA in di¡erent preparations was quanti-
¢ed with a LKB 2202 UnitroScan Laser Densitom-
eter (LKB, Bromma, Sweden), normalized against
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levels of GAPDH mRNA in each sample, and ex-
pressed as a percentage of the control value. The
data are presented as the mean þ S.E. of measure-
ments from triplicate cultures for one representative
experiment. Comparisons between groups were per-
formed by one-way ANOVA. The signi¢cance of dif-
ferences between the mean values in the control
group and each treated group was determined by
Duncan’s multiple comparison test. A value of
P6 0.05 was considered statistically signi¢cant.
3. Results
Previously, we have investigated the regulation of
ovarian midkine production at the mRNA level and
shown the stimulatory e¡ects of FSH and RA on the
midkine mRNA in rat granulosa cells. However,
although FSH and RA independently increased mid-
kine mRNA level, midkine mRNA expression was
not increased relative to stimulation with FSH and
RA alone even when the same doses of FSH and RA
Fig. 2. Dose-related e¡ect of RA on FSH-induced FSH-R mRNA. (A) Granulosa cells from DES-primed immature rats were cultured
alone for 24 h. They were then cultured with 30 ng/ml FSH alone and FSH (30 ng/ml) plus increasing concentrations of RA for a
further 48 h. FSH-R mRNA levels were measured using the Northern blot analysis, as described in Section 2. (B) Luminescence de-
tection of FSH-R mRNA (2.4 kb) were quanti¢ed by densitometric scanning. The amount of FSH-R mRNA cultured with FSH alone
after 24 h was taken as 100%. Data were normalized for GAPDH mRNA levels in each sample and expressed relative to the control.
The absorbancy values obtained from this experiment as well as those from two other studies were standardized relative to the control
and are represented (mean þ S.E.; n = 4) in the bar graphs. *P6 0.05. **P6 0.01.
Fig. 1. The e¡ect of RA over time on the FSH-induced FSH-R mRNA. (A) Granulosa cells from DES-primed immature rats were
cultured alone for 24 h. These cells were then further incubated without FSH and with FSH (30 ng/ml) and with a combination of
FSH (30 ng/ml) plus RA (1037 M). After various incubation times, total RNA was extracted and FSH-R mRNA levels were mea-
sured using Northern blot analysis as described in Section 2. (B) Luminescence detection of FSH-R mRNA (2.4 kb) were quanti¢ed
by densitometric scanning. The amount of FSH-R mRNA with FSH alone after 24 h was taken as 100%. Data were normalized for
GAPDH mRNA levels in each sample and expressed as a value relative to the control (FSH alone 24 h). The absorbancy values ob-
tained from this experiment as well as those from the two other experiments were standardized in relation to the 24-h control and are
represented (mean þ S.E.; n = 3) in the graph. *P6 0.05.
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were applied simultaneously. Then we have shown
that RA inhibits the e¡ect of FSH on FSH-R induc-
tion [35]. In this study, to examine the e¡ect of RA
on the FSH-R mRNA levels, granulosa cells were
cultured with FSH 30 ng/ml in both the presence
and absence of RA (Fig. 1). As was expected, treat-
ment with FSH produced a substantial increase in
the FSH-R mRNA level and the addition of RA
(1037 M) caused a signi¢cant decrease of FSH-in-
duced FSH-R mRNA during incubation. Concurrent
treatment with increasing concentrations of RA
brought about dose-dependent decreases in FSH-in-
duced FSH-R mRNA. The presence of 1038 M RA
signi¢cantly reduced FSH-induced FSH-R mRNA
after 48 h of incubation (Fig. 2).
It is known that the action of FSH is mediated by
cAMP and that a considerable amount of cAMP is
accumulated in granulosa cells. It has been shown
that FSH increased intracellular cAMP levels; how-
ever, RA either alone or in combination with FSH,
did not have an signi¢cant e¡ect on the intracellular
cAMP levels (Table 1). As shown in Fig. 3, treatment
with 8-Br-cAMP (0.5 mM) produced a signi¢cant
increase in FSH-R mRNA, and concurrent treatment
with RA (1039 M) induced a signi¢cant decrease in
8-Br-cAMP action, suggesting that RA inhibited the
action of FSH at sites distal to cAMP generation in
the granulosa cell.
Whether RA regulation of FSH-R mRNA is de-
pendent on gene transcription and/or receptor
mRNA stability was also examined. The following
set of experiments were designed to elucidate the
potential contribution made by changes in FSH re-
ceptor gene transcription to the regulation of FSH-R
mRNA. To test whether RA has an e¡ect on tran-
scription of the FSH-R gene in the presence of FSH,
nuclear run-on assays on granulosa cells were per-
formed. As shown in Fig. 4, FSH-R gene transcrip-
tion was signi¢cantly inhibited by treatment with RA
Fig. 3. The e¡ect of RA on 8-Br-cAMP-induced FSH-R mRNA. (A) Granulosa cells from DES-primed immature rats were cultured
alone for 24 h. They were then cultured with 8-Br-cAMP (0.5 mM) alone and 8-Br-cAMP (0.5 mM) plus increasing concentrations of
RA for a further 48 h. FSH-R mRNA levels were measured using the Northern blot analysis, as described in Section 2. (B) Lumines-
cence detection of FSH-R mRNA (2.4 kb) were quanti¢ed by densitometric scanning. The amount of FSH-R mRNA cultured with
FSH alone was taken as 100%. Data were normalized for GAPDH mRNA levels in each sample and expressed as a value relative to
the control (8-Br-cAMP alone). The absorbancy values obtained from this experiment as well as those from the two experiments were
standardized to the control and are represented (mean þ S.E.; n = 3) in the graph. *P6 0.05.
Table 1
E¡ect of RA on FSH-induced intracellular cAMP accumulation
in rat granulosa cells
Treatment cAMP accumulation
(pmol/5U105 cells)
Control 0.06 þ 0.03
FSH 30 ng/ml 38.35 þ 0.51
FSH 30 ng/ml+RA 1U10310 M 34.65 þ 1.59
FSH 30 ng/ml+RA 1U1039 M 34.73 þ 1.73
FSH 30 ng/ml+RA 1U1038 M 33.32 þ 3.82
FSH 30 ng/ml+RA 1U1037 M 32.00 þ 2.14
FSH 30 ng/ml+RA 1U1036 M 31.67 þ 1.04
RA 1U1036 M 0.08 þ 0.01
This table is representative of three di¡erent experiments.
BBAMCR 14593 17-2-00
T. Minegishi et al. / Biochimica et Biophysica Acta 1495 (2000) 203^211 207
in granulosa cells. These data, therefore, suggest that
the down-regulation of RA on FSH-R induction is
mediated by a decrease in FSH-R gene transcription.
In order to assess the rates of degradation of FSH-
R mRNA transcripts, granulosa cells were preincu-
bated with FSH alone or with FSH and RA for 24 h.
As shown in Fig. 5, the decay curves for the 2.4-kb
FSH receptor mRNA transcript in primary granulo-
sa cells showed no signi¢cant change in the presence
of RA.
4. Discussion
Recent data show that granulosa cells from the
ovaries of eCG-treated immature rats and luteal cells
Fig. 5. E¡ect of RA on FSH-R mRNA transcripts. (A) Granulosa cells were preincubated for 48 h with FSH (30 ng/ml) alone or
with FSH (30 ng/ml) and RA (1038 M). After this preincubation period, 5 mM actinomycin-D was added to arrest new RNA synthe-
sis. Cells were harvested at 0, 3, 6, and 9 h after the addition of the transcription inhibitor, and FSH receptor mRNA levels were
quantitated by the Northern blot analysis. In this experiment, the level of GAPDH mRNA obtained from both FSH and FSH plus
retinoic acid treated cells relatively decreased with time. (B) The mRNA levels at time zero were assigned a relative value of 100%,
and mRNA levels at all other times are expressed as percentages of this time zero value.
Fig. 4. Stimulation of FSH-R gene transcription by FSH and RA. (A) Granulosa cells were cultured in 60-mm dishes containing
5U106 cells in 5 ml serum-free medium. After 24 h in culture, granulosa cells were incubated in the presence or absence of RA (1038
M) for a further 24 h and nuclear run-on assays were then performed as described in Section 2. (B) Data acquired from the nuclear
run-on experiments shown in (A) were quantitated by a £uoro-image analyzer (BAS 2000). Data were normalized for L-actin levels in
each sample and are expressed relative to the control value. Transcriptional activities after incubation with FSH and RA are expressed
relative to the activity a¡ected by FSH alone. The data shown are means þ S.E. of the three independent experiments. *P6 0.05,
**P6 0.01.
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from the ovaries of eCG/hCG-treated immature rats,
synthesized markedly higher amounts of retinoic acid
when cultured alone, compared to granulosa cells
cultured from the ovaries of the prepubertal rat
treated with the control vehicle [36]. Moreover, the
presence of RARs in ovary cells, including granulosa
cells, germinal epithelial cells, and some luteal cells,
indicate that these cells would also be targets for
retinoic acid [18]. These data suggest that retinoic
acid may regulate the ovarian function by autocrine
and/or paracine action.
Previous results indicate that retinoic acid (10310
M) and retinol (1038 M) each synergistically enhance
the ability of FSH to induce LH-R and stimulate the
formation of cAMP and progesterone. And at higher
concentrations, both retinoids inhibited these e¡ects
of FSH [37,38]. Moreover, the e¡ects of retinoids on
cultured rat Sertoli cells were studied by evaluating
cAMP and estradiol production after gonadotropin
stimulation in the presence or absence of the reti-
noid. Sertoli cells cultured in the presence of FSH
produce large quantities of cAMP and show in-
creased aromatase activity. The addition of retinol
alone has no e¡ect on cAMP and estradiol produc-
tion, while the presence of retinol in the culture me-
dium exerts an inhibitory e¡ect on the Sertoli cell
response to FSH stimulation. The inhibitory e¡ect
of retinoids on FSH-stimulated aromatase activity
of Sertoli cells, which is cAMP mediated, was also
evident [39]. However, Table 1 showed that the ad-
dition of RA did not cause a signi¢cant change in the
levels of FSH-induced intracellular cAMP in rat
granulosa cell. Although, we do not know the rea-
sons for this di¡erence so far, it might be due to the
way of measurement of cAMP. In the present study,
the level of cAMP in the cells was measured after the
short incubation time in order to avoid the indirect
e¡ect from other factors, which is present in the me-
dium during the incubation. This study provides evi-
dence for a dramatic down-modulation of the FSH-
R mRNA when RA is added to granulosa cells in the
presence of FSH. The receptor depletion by RA was
concentration dependent, and RA (1038 M) abol-
ished the e¡ect of FSH on FSH receptor mRNA.
The use of this de¢ned culture system has showed
that the ability of FSH to stimulate the induction
of FSH receptors is mediated, at least in part, by
cAMP, since exogenous cAMP or other agents that
increase intracellular levels of cAMP mimic the ac-
tions of FSH [9]. The response of FSH-R mRNA to
cAMP analogs was inhibited by RA in granulosa
cells in this experiment, suggesting that RA dimin-
ished the action of FSH at sites distal to cAMP gen-
eration in the granulosa cells.
The observed inhibition of message levels of FSH-
R by RA may be the result of decreased FSH-R gene
transcription and/or message stability. Determination
of the transcriptional mechanisms that regulate FSH-
R expression in the gonads will provide important
insights into both cell-speci¢c transcriptional events
that are important for gonadal function and the
mechanisms that control the response of the gonads
to FSH through the modulation of receptor levels.
The experiment for the decay of FSH-R mRNA was
performed in cells pretreated for 24 h with FSH and
FSH plus RA. The data presented demonstrates that
RA did not change the FSH-R mRNA stability in
rat granulosa cells.
Although FSH signi¢cantly stimulates the rate of
transcription of the FSH-R gene, the results of the
nuclear run-on experiments demonstrate that RA in-
hibits the rate of transcription of the FSH-R gene. It
seems probable that di¡erent members of the steroid/
retinoid hormone receptor superfamily may act using
similar mechanisms. For example, transcriptional re-
pression may act either by receptor competition with
positive transactivating factors for DNA binding to
overlapping sequences or by interference with their
transactivating action through direct protein^protein
interaction. As described in a paper by Goetz et al.
[14], an E box is required for full promoter function
of the rat FSH-R gene. The promoters of the rat,
human, sheep, and mouse FSH-R genes all contain
an E box consensus sequence, CANNTG, which is
known to bind members of the basic helix-loop-helix
(bHLH) family of proteins that consist mostly of
transcriptional regulators involved in the control of
growth and di¡erentiation [12,13,40^45]. For exam-
ple, the inhibitor of DNA binding (Id) is a dominant
negative regulator of the bHLH/HLHZ proteins as it
lacks the basic region for DNA binding, but has the
helix-loop-helix domain for dimerization. Thus it can
dimerize with other bHLH/HLHZ proteins and pre-
vent their binding to the E box consensus site [46].
Co-transfection of the Id with an FSH-R luciferase
construct into mouse Sertoli cell line (MSC-1) re-
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duced FSH-R promoter activity [14]. In addition, it
was concluded that the decrease in promoter activity
was most likely due to the sequestration of the en-
dogenous upstream stimulatory factor (USF) by Id,
which prevented it binding to the E box consensus
site. In a previous experiment [47], transient trans-
fection assays in the human T-lymphoblastoid cell
line Jurkat demonstrated that the activation of the
IFN-Q promoter was signi¢cantly down-regulated in
the presence of RA. These data suggest that the in-
hibition of the INF-Q promoter is one of the possible
mechanisms operating in the retinoid-mediated neg-
ative regulation of the INF-Q gene. Also the data
show the potential relevance of regulatory interac-
tions between RARs and E box-related binding fac-
tors in the modulation of the IFN-Q promoter in T
lymphocytes. Taken together, RA may interact with
the promoter region of FSH-R in a similar manner
to the promoter of IFN-Q thus resulting in the down-
regulation of FSH-R expression.
In conclusion, the data presented here show that
RA has an e¡ect on FSH receptor regulation, sug-
gesting that one of the possible mechanisms respon-
sible for this e¡ect is the modulation of the FSH-R
promoter activity by RA. Further characterization of
both the FSH-R gene and its promoter region is
required to complete our understanding of the tran-
scriptional mechanisms activating FSH-R in granu-
losa cells.
Acknowledgements
We thank the National Hormone and Pituitary
Agency, National Institute of Arthritis, Diabetes
and Digestive and Kidney Diseases, University of
Maryland School of Medicine for the rat FSH.
This work was supported by grants from the Minis-
try of Education, Science and Culture of Japan
(10044235, 10877253), Tokyo, Japan.
References
[1] R. Sprengel, T. Braun, K. Nikolics, D.L. Segalo¡, P.H. See-
burg, Mol. Endocrinol. 4 (1990) 525^530.
[2] K.C. McFarland, R. Sprengel, H.S. Phillips, M. Kohler, N.
Rosemblit, K. Nikolics, D.L. Segalo¡, P.H. Seeburg, Science
245 (1989) 494^499.
[3] H. Loosfelt, M. Misrahi, M. Atger, R. Salesse, M.T. Vu Hai
Luu Thi, A. Jolivet, A. Guiochon Mantel, S. Sar, B. Jallal, J.
Garnier et al., Science 245 (1989) 525^528.
[4] M. Parmentier, F. Libert, C. Maenhaut, A. Lefort, C. Ger-
ard, J. Perret, J. Van Sande, J.E. Dumont, G. Vassart, Sci-
ence 246 (1989) 1620^1622.
[5] A.P. Themmen, R. Kraaij, J.A. Grootegoed, Mol. Cell En-
docrinol. 100 (1994) 15^19.
[6] T.A. Camp, J.O. Rahal, K.E. Mayo, Mol. Endocrinol. 5
(1991) 1405^1417.
[7] K. Nakamura, T. Minegishi, Y. Takakura, K. Miyamoto, Y.
Hasegawa, Y. Ibuki, M. Igarashi, Mol. Cell Endocrinol. 82
(1991) 259^263.
[8] P.S. LaPolt, J.L. Tilly, T. Aihara, K. Nishimori, A.J. Hsueh,
Endocrinology 130 (1992) 1289^1295.
[9] J.L. Tilly, P.S. LaPolt, A.J. Hsueh, Endocrinology 130
(1992) 1296^1302.
[10] J.S. Richards, L. Hedin, Annu. Rev. Physiol. 50 (1988) 441^
463.
[11] C.C. Linder, L.L. Heckert, T.L. Goetz, M.D. Griswold, En-
docrine 2 (1994) 957^966.
[12] J. Gromoll, B. Dankbar, T. Gudermann, Mol. Cell Endo-
crinol. 102 (1994) 93^102.
[13] I.T. Huhtaniemi, V. Eskola, P. Pakarinen, T. Matikainen, R.
Sprengel, Mol. Cell Endocrinol. 88 (1992) 55^66.
[14] T.L. Goetz, T.L. Lloyd, M.D. Griswold, J. Biol. Chem. 271
(1996) 33317^33324.
[15] P.A. Laurence, A.E. Sobel, J. Clin. Endocrinol. Metab. 13
(1953) 1192^1199.
[16] A.B. Ragins, H. Popper, Arch. Pathol. 34 (1942) 647^654.
[17] P. Chambon, FASEB J. 10 (1996) 940^954.
[18] Y.H. Zhuang, T. Ylikomi, M. Lindfors, S. Piippo, P. Tuo-
himaa, J. Steroid Biochem. Mol. Biol. 48 (1994) 61^68.
[19] A.B. Roberts, M.B. Sporn, in: M.B. Sporn, A.B. Roberts,
D.S. Goodman (Eds.), The Retinoids, Vol. 2, Academic
Press, Orlando, FL, 1984, pp. 209^286.
[20] L.M. De Luca, FASEB J. 5 (1991) 2924^2933.
[21] R.M. Evans, Science 240 (1988) 889^895.
[22] J.P. Brockes, Neuron 2 (1989) 1285^1294.
[23] S. Strickland, V. Mahdavi, Cell 15 (1978) 393^403.
[24] P. Chambon, Semin. Cell Biol. 5 (1994) 115^125.
[25] C.K. Glass, Endocr. Rev. 15 (1994) 391^407.
[26] M. Leid, P. Kastner, P. Chambon, Trends Biochem. Sci. 17
(1992) 427^433.
[27] L.G. Hudson, J.B. Santon, C.K. Glass, G.N. Gill, Cell 62
(1990) 1165^1175.
[28] S.M. Lipkin, C.A. Nelson, C.K. Glass, M.G. Rosenfeld,
Proc. Natl. Acad. Sci. USA 89 (1992) 1209^1213.
[29] M. Beato, FASEB J. 5 (1991) 2044^2051.
[30] M. Nakamura, T. Minegishi, Y. Hasegawa, K. Nakamura,
S. Igarashi, I. Ito, H. Shinozaki, K. Miyamoto, Y. Eto, Y.
Ibuki, Endocrinology 133 (1993) 538^544.
[31] M. Hattori, K. Ozawa, K. Wakabayashi, Biochem. Biophys.
Res. Commun. 127 (1985) 501^508.
BBAMCR 14593 17-2-00
T. Minegishi et al. / Biochimica et Biophysica Acta 1495 (2000) 203^211210
[32] P. Chomczynski, N. Sacchi, Anal. Biochem. 162 (1987) 156^
159.
[33] T. Minegishi, H. Kishi, M. Tano, T. Kameda, T. Hirakawa,
K. Miyamoto, Mol. Cell. Endocrinol. 149 (1999) 71^77.
[34] M. Tano, T. Minegishi, K. Nakamura, S. Karino, Y. Ibuki,
K. Miyamoto, J. Endocrinol. 153 (1997) 465^473.
[35] T. Minegishi, S. Karino, M. Tano, Y. Ibuki, K. Miyamoto,
Biochem. Biophys. Res. Commun. 229 (1996) 799^805.
[36] W.L. Zheng, R.A. Bucco, E. Sierra Rievera, K.G. Osteen,
M.H. Melner, D.E. Ong, Biol. Reprod. 60 (1999) 110^
114.
[37] P. Bagavandoss, A.R. Midgley Jr., Endocrinology 121 (1987)
420^428.
[38] P. Bagavandoss, A.R. Midgley Jr., Life Sci. 43 (1988) 1607^
1614.
[39] M. Galdieri, L. Nistico, Biol. Reprod. 50 (1994) 171^177.
[40] T.D. Littlewood, G.I. Evan, Protein Pro¢le 1 (1994) 635^
709.
[41] A.B. Lassar, S.X. Skapek, B. Novitch, Curr. Opin. Cell Biol.
6 (1994) 788^794.
[42] J.E. Lee, Curr. Opin. Neurobiol. 7 (1997) 13^20.
[43] J. Garrell, S. Campuzano, Bioessays 13 (1991) 493^498.
[44] C. Murre, P.S. McCaw, H. Vaessin, M. Caudy, L.Y. Jan,
Y.N. Jan, C.V. Cabrera, J.N. Buskin, S.D. Hauschka, A.B.
Lassar et al., Cell 58 (1989) 537^544.
[45] M.R. Sairam, V.S. Subbarayan, Mol. Reprod. Dev. 48
(1997) 480^487.
[46] R. Benezra, R.L. Davis, D. Lockshon, D.L. Turner, H.
Weintraub, Cell 61 (1990) 49^59.
[47] M. Cippitelli, J. Ye, V. Viggiano, A. Sica, P. Ghosh, A.
Gulino, A. Santoni, H.A. Young, J. Biol. Chem. 271
(1996) 26783^26793.
BBAMCR 14593 17-2-00
T. Minegishi et al. / Biochimica et Biophysica Acta 1495 (2000) 203^211 211
